| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $25.19B | $25.17B | $22.70B |
| YoY Revenue Growth % | +0.1% | +10.9% | — |
| Gross Profit | $6.57B | $7.37B | — |
| Gross Margin % | 26.1% | 29.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $6.52B | $6.86B | $6.22B |
| Operating Margin % | 25.9% | 27.3% | 27.4% |
| Net Income (GAAP) | $2.20B | $1.89B | $1.85B |
| EBITDA (Normalized) | $7.42B | $7.77B | $7.04B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $5.61B | $7.16B | $5.28B |
| Capital Expenditures (CapEx) | $1.13B | $1.13B | $1.02B |
| Free Cash Flow (FCF) | $4.48B | $6.03B | $4.26B |
| FCF Margin % | 17.8% | 23.9% | 18.8% |
| Return on Invested Capital (ROIC %) | 21.5% | 24.0% | 15.6% |
| Cash & Short-Term Equivalents | $3.82B | $3.92B | — |
| Total Debt (Short + Long Term) | $8.91B | $8.91B | $12.22B |
| Total Stockholders' Equity | $18.90B | $17.58B | $25.07B |